Skip to content

Can You Take Terbinafine and Vyvanse Together? A Guide to the Risks

4 min read

Terbinafine is a known inhibitor of the CYP2D6 enzyme, which can significantly alter the metabolism of other medications. This raises serious safety questions about whether you can take terbinafine and vyvanse together, as this combination can increase the risk of severe side effects, including cardiovascular issues and serotonin syndrome.

Quick Summary

Taking terbinafine and Vyvanse together is risky due to a serious drug interaction involving the CYP2D6 enzyme. Terbinafine can increase Vyvanse levels, elevating the potential for cardiovascular issues, seizures, and serotonin syndrome. This combination requires strict medical supervision and is often best avoided.

Key Points

  • Significant Drug Interaction: Terbinafine significantly inhibits the CYP2D6 enzyme, which metabolizes the active component of Vyvanse, leading to a dangerous drug interaction.

  • Increased Vyvanse Levels: This inhibition can lead to increased blood concentrations of dextroamphetamine, the active form of Vyvanse, raising the risk of toxicity.

  • Elevated Health Risks: The combination can increase the risk of serious side effects, including severe cardiovascular issues, seizures, and the rare but life-threatening condition of serotonin syndrome.

  • Requires Medical Supervision: Taking both medications concurrently is not recommended and should only be considered under strict medical supervision with careful monitoring for adverse effects and potential dosage adjustments.

  • Consultation is Crucial: Before starting any new medication, especially if you are already on Vyvanse, you must inform your doctor of all your current medications to prevent dangerous interactions.

  • Look for Alternatives: If a fungal infection requiring terbinafine is present, a healthcare provider may opt for a different antifungal medication or adjust the Vyvanse treatment to avoid the interaction.

In This Article

Understanding the Terbinafine and Vyvanse Interaction

Mixing different medications can lead to unexpected and potentially dangerous outcomes. In the case of terbinafine and Vyvanse, the interaction is significant and can increase the risk of serious health complications. The root of the problem lies in how each medication is processed by the body and their respective effects on a specific enzyme system.

The Pharmacological Mechanism Explained

Terbinafine, an antifungal medication commonly used for conditions like athlete's foot and nail fungus, is a potent inhibitor of the cytochrome P450 2D6 (CYP2D6) enzyme. This enzyme is part of the body's primary detoxification system, located mainly in the liver, and is responsible for metabolizing many drugs.

Vyvanse (lisdexamfetamine) is a central nervous system stimulant used to treat ADHD and binge eating disorder. It is a prodrug, meaning it is inactive until the body processes it. Upon ingestion, lisdexamfetamine is converted into its active form, dextroamphetamine, predominantly by enzymes in red blood cells. While the initial conversion of lisdexamfetamine bypasses the liver, the subsequent metabolism and clearance of the active dextroamphetamine component rely on the CYP2D6 enzyme.

When terbinafine inhibits CYP2D6, it slows down the clearance of dextroamphetamine from the body. This results in elevated and prolonged blood levels of dextroamphetamine, effectively magnifying the effects of Vyvanse and increasing the risk of dose-related toxicity.

Potential Risks and Adverse Effects of Concurrent Use

The elevated blood levels of dextroamphetamine can lead to a heightened risk and severity of side effects associated with Vyvanse. These potential risks include:

  • Cardiovascular Complications: A significant increase in heart rate and blood pressure can occur, which may put a strain on the cardiovascular system. In severe cases, this could lead to dangerously high blood pressure or irregular heart rhythms.
  • Serotonin Syndrome: Combining these medications can increase the risk of developing serotonin syndrome, a rare but life-threatening condition caused by too much serotonin activity in the brain. Symptoms can range from mild (shivering, diarrhea) to severe (seizures, high fever, irregular heartbeat).
  • Neurological Effects: The risk of seizures is elevated, especially for individuals with a pre-existing seizure disorder or a history of seizures. Other neurological side effects may include increased nervousness, confusion, hallucinations, and agitation.
  • Circulation Issues: Increased blood levels of dextroamphetamine can also worsen circulation problems, causing numbness or pain in the fingers and toes, a condition known as Raynaud's phenomenon.
  • Gastrointestinal Distress: A magnified effect of Vyvanse can also contribute to gastrointestinal issues like loss of appetite, nausea, and stomach cramps.

Management and Medical Consultation

The concurrent use of terbinafine and Vyvanse is generally not recommended due to the high risk of a clinically significant drug interaction. If this combination is medically necessary, the treatment must be managed under strict and careful medical supervision. A doctor may consider several strategies:

  • Dosage Adjustments: A lower dose of Vyvanse may be required to counteract the effect of terbinafine and maintain therapeutic levels of dextroamphetamine.
  • Alternative Medications: The healthcare provider might consider alternative medications for either the fungal infection or ADHD that do not interact with the CYP2D6 pathway.
  • Close Monitoring: The patient will need to be closely monitored for adverse effects, especially cardiovascular and neurological symptoms, throughout the treatment period.

Comparison Table: Terbinafine vs. Vyvanse

Feature Terbinafine Vyvanse (Lisdexamfetamine)
Drug Class Antifungal Central Nervous System Stimulant
Primary Use Fungal infections of the nails (onychomycosis), skin (tinea) Attention-Deficit/Hyperactivity Disorder (ADHD), Binge Eating Disorder (BED)
Mechanism of Action Inhibits fungal enzyme squalene epoxidase; Inhibits human CYP2D6 enzyme Prodrug converted to dextroamphetamine; Increases levels of dopamine and norepinephrine
Metabolism Pathway Multiple CYP enzymes, but a potent inhibitor of CYP2D6 Hydrolyzed by red blood cells; Active metabolite (dextroamphetamine) is metabolized by CYP2D6
Half-Life Long, leading to persistent effects even after stopping Relatively shorter, but affected by terbinafine
Drug Interaction Risk High, especially with drugs metabolized by CYP2D6 like Vyvanse High, especially when combined with strong CYP2D6 inhibitors like terbinafine

Conclusion

In summary, the combination of terbinafine and Vyvanse presents a significant and serious drug interaction risk. Terbinafine's potent inhibition of the CYP2D6 enzyme leads to an accumulation of Vyvanse's active component, dextroamphetamine, in the body. This can escalate the risk of dangerous cardiovascular side effects, seizures, and serotonin syndrome. Due to the inherent dangers, this drug combination should be avoided whenever possible. Patients who are prescribed both medications must be closely monitored by a healthcare professional, and they should immediately report any concerning symptoms. Always disclose all medications, including over-the-counter drugs and supplements, to your doctor before beginning any new treatment. A medical professional is the only one who can safely assess the risks and determine the best course of action for your individual health needs.

Potential Symptoms of the Interaction

If you are taking terbinafine and Vyvanse, and you suspect an interaction, be aware of these potential symptoms:

  • Increased nervousness or anxiety
  • Restlessness or agitation
  • Rapid or pounding heartbeat
  • Elevated blood pressure
  • Chest pain
  • Hallucinations
  • Fever
  • Excessive sweating
  • Shivering or shaking
  • Nausea, vomiting, or diarrhea
  • Loss of appetite
  • Circulation problems in fingers and toes
  • Seizures

If you experience any of these symptoms, you should contact your doctor or seek emergency medical help immediately.

Frequently Asked Questions

It is dangerous because terbinafine inhibits the CYP2D6 enzyme, which is responsible for metabolizing the active ingredient of Vyvanse (dextroamphetamine). This can lead to increased levels of dextroamphetamine in the body, raising the risk of serious side effects like cardiovascular problems, seizures, and serotonin syndrome.

Combining terbinafine and Vyvanse can cause a significant increase in heart rate and blood pressure due to elevated dextroamphetamine levels. This can increase cardiac workload and potentially lead to more severe cardiovascular events.

Serotonin syndrome is a potentially life-threatening condition caused by excessive serotonin activity in the brain. The risk of this syndrome can be increased when combining Vyvanse with medications like terbinafine, especially when other serotonergic agents are also involved. Symptoms include confusion, hallucination, rapid heartbeat, and fever.

If your doctor prescribes both medications, they should be aware of the interaction and manage your treatment carefully. You should report any side effects immediately. In many cases, a doctor may recommend an alternative treatment for one of the conditions to avoid the interaction altogether.

While oral terbinafine carries a much higher risk due to systemic absorption and liver metabolism, it is always wise to consult your doctor about any medication, including topical creams, to confirm its safety with your current prescription list. The risk of interaction with topical application is lower, but should not be assumed to be non-existent without medical advice.

Due to terbinafine's long half-life, its inhibitory effects on the CYP2D6 enzyme can persist for several weeks after the last dose. You must consult your doctor to determine the appropriate and safe timing for resuming Vyvanse, as it depends on your specific health and metabolism.

Yes, there are other antifungal medications available. Your healthcare provider can evaluate your medical history and other medications to determine a safer alternative to terbinafine that doesn't significantly inhibit the CYP2D6 pathway. Always discuss all your treatment options with your doctor.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.